U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Forms & Submission Requirements
  5. Electronic Regulatory Submission and Review
  6. Data Standards Manual (monographs)
  7. SPL DEA Schedule (Drugs)
  1. Data Standards Manual (monographs)

SPL DEA Schedule (Drugs)

FDA Data Element Number. Pending.

CDER Data Element Number. C-DRG-0933

Data Element Name. SPL DEA SCHEDULE

Data Element OID: n/a

Data Element NCI ConceptID: C48670

Version Number: 001

Description. The abuse potential category to which an active ingredient, or combination of active ingredients, is assigned, as regulated by both the United States Drug Enforcement Administration (DEA) and the United States Food and Drug Administration.

Source. 21 USC Sec. 812 (see http://www.usdoj.gov/dea/pubs/csa/812.htm); 21CFR1302.03; 21CFR1308

Relationship. None.

FDA Specifications.

CDER Specifications. No further specifications.

FDA Approved Date. 14-SEP-2005

CDER Approved Date. 14-SEP-2005

FDA Revised Date.

CDER Revised Date.

Data Values.

CISchedule IC48672
CIISchedule IIC48675
CIIISchedule IIIC48676
CIVSchedule IVC48677
CVSchedule VC48679


Back to Top